Wondfo Biotech Secures Regulatory Approval for New Diagnostic Product

Stock News05-06

Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ) has announced that it recently obtained a medical device registration certificate from the National Medical Products Administration. The certificate pertains to the "Hepatitis B Virus (HBV) Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method)." The successful market approval of this HBV nucleic acid test kit represents a significant milestone in the company's molecular diagnostics business strategy. Wondfo Biotech will further enhance its molecular diagnostics portfolio, enrich its infectious disease testing product lineup, and optimize its overall product structure and strategic layout.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165184955?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 16:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165184955","market":"sh","top_or_hot":-1,"title":"Wondfo Biotech Secures Regulatory Approval for New Diagnostic Product","media":"Stock News","content":"<p>Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ) has announced that it recently obtained a medical device registration certificate from the National Medical Products Administration. The certificate pertains to the \"Hepatitis B Virus (HBV) Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method).\" The successful market approval of this HBV nucleic acid test kit represents a significant milestone in the company's molecular diagnostics business strategy. Wondfo Biotech will further enhance its molecular diagnostics portfolio, enrich its infectious disease testing product lineup, and optimize its overall product structure and strategic layout.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wondfo Biotech Secures Regulatory Approval for New Diagnostic Product</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWondfo Biotech Secures Regulatory Approval for New Diagnostic Product\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-06 16:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ) has announced that it recently obtained a medical device registration certificate from the National Medical Products Administration. The certificate pertains to the \"Hepatitis B Virus (HBV) Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method).\" The successful market approval of this HBV nucleic acid test kit represents a significant milestone in the company's molecular diagnostics business strategy. Wondfo Biotech will further enhance its molecular diagnostics portfolio, enrich its infectious disease testing product lineup, and optimize its overall product structure and strategic layout.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"","article_id":"1165184955","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165184955","pubTimestamp":1778054416,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ) has announced that it recently obtained a medical device registration certificate from the National Medical Products Administration. The certificate...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300482":"万孚生物","BK0239":"医药制造","BK0046":"生物疫苗","BK0197":"中小创蓝筹"},"translate_title":"万孚生物新诊断产品获得监管部门批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300482":1},"content_text":"Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ) has announced that it recently obtained a medical device registration certificate from the National Medical Products Administration. The certificate pertains to the \"Hepatitis B Virus (HBV) Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method).\" The successful market approval of this HBV nucleic acid test kit represents a significant milestone in the company's molecular diagnostics business strategy. Wondfo Biotech will further enhance its molecular diagnostics portfolio, enrich its infectious disease testing product lineup, and optimize its overall product structure and strategic layout.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165184955","isCrawlerRequest":true}